These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26710542)

  • 21. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution and drug susceptibilities of clinical Candida species in TSARY 2014.
    Zhou ZL; Lin CC; Chu WL; Yang YL; Lo HJ;
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):399-404. PubMed ID: 27717650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007)].
    Rodríguez AZ; Gómez Cde B; Restrepo CA; Parra HH; Arteaga MA; Moreno AR; Marín AG
    Rev Iberoam Micol; 2010 Sep; 27(3):125-9. PubMed ID: 20450982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC; Lo HJ; Fung CP; Lee N; See LC
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    Minea B; Nastasa V; Moraru RF; Kolecka A; Flonta MM; Marincu I; Man A; Toma F; Lupse M; Doroftei B; Marangoci N; Pinteala M; Boekhout T; Mares M
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):367-83. PubMed ID: 25224578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
    Porte L; León P; Gárate C; Guzmán AM; Labarca J; García P
    Rev Chilena Infectol; 2012 Apr; 29(2):149-55. PubMed ID: 22689028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals.
    Zaoutis TE; Foraker E; McGowan KL; Mortensen J; Campos J; Walsh TJ; Klein JD
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):295-8. PubMed ID: 15922535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN; Doern GV; Brandt ME; Hajjeh RA
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):217-22. PubMed ID: 10212747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
    Madhavan P; Jamal F; Chong PP; Ng KP
    Trop Biomed; 2010 Aug; 27(2):200-7. PubMed ID: 20962716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
    Lima GME; Nunes MO; Chang MR; Tsujisaki RAS; Nunes JO; Taira CL; Thomaz DY; Negro GMBD; Mendes RP; Paniago AMM
    Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e75. PubMed ID: 29267583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.
    Colombo AL; Da Matta D; De Almeida LP; Rosas R
    Braz J Infect Dis; 2002 Jun; 6(3):118-23. PubMed ID: 12144747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.
    Tan TY; Tan AL; Tee NW; Ng LS
    Ann Acad Med Singap; 2008 Oct; 37(10):835-40. PubMed ID: 19037517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.
    Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM
    Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
    Dóczi I; Mestyán G; Puskás E; Nikolova R; Barcs I; Nagy E
    Acta Microbiol Immunol Hung; 2006 Jun; 53(2):135-44. PubMed ID: 16956125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.